Literature DB >> 17460246

Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts.

Sun-Ah Jung1, Hyung Keun Lee, Jin Sook Yoon, Sung-Joo Kim, Chan Yoon Kim, Heesang Song, Ki-Chul Hwang, Jong Bok Lee, Joon H Lee.   

Abstract

PURPOSE: Excessive scarring in subconjunctival tissues after filtering surgery seems to be characterized by aberrant extracellular matrix (ECM) production, and tissue transglutaminase (tTgase) plays an important role in this process. In the present study, the effects of transforming growth factor (TGF)-beta2 on the expression of tTgase, its activity in subconjunctival fibroblasts and whether the effects of TGF-beta are mediated by prosurvival signaling pathways were examined.
METHODS: Primary subconjunctival fibroblasts treated with TGF-beta2 were examined for the expression of tTgase with Western blot analysis. The modulation of extracellular tTgase activity by TGF-beta2 was measured by both the formation of fibronectin polymers and the ECM protein incorporation of fluorescein cadaverine. The expression of tTgase was analyzed by immunofluorescence staining and Western blot analysis of subconjunctival fibroblasts that were transiently transfected with an Akt dominant negative mutant gene or were treated with an Akt inhibitor or tTgase siRNA.
RESULTS: Treatment of subconjunctival fibroblasts with TGF-beta2 caused an increase in activation and expression of tTgase. The effects of TGF-beta stimulation of subconjunctival fibroblasts were twofold, causing both rapid activation of the ERK pathway within minutes of treatment and a more delayed activation of the phosphatidylinositol3-kinase-protein kinase B (PKB)/Akt pathway; however, only Akt activation was necessary for TGF-beta-induced tTgase expression. Transient transfection of subconjunctival fibroblasts with an Akt dominant negative mutant gene, or treatment with an Akt inhibitor (but not with an ERK inhibitor) or tTgase siRNA led to decreased activation and expression of tTgase.
CONCLUSIONS: TGF-beta2 activated the PI3K-Akt pathway, and this activation was essential for the expression and activity of tTgase in subconjunctival fibroblasts. The results indicate a novel biological function of the PI3K-Akt pathway in subconjunctival fibroblasts. Elevated expression and activity of tTgase may play an important role in the pathogenesis of diseases related to wound healing and fibrogenic reactions in subconjunctival fibroblasts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460246     DOI: 10.1167/iovs.06-1164

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  15 in total

Review 1.  Cellular functions of tissue transglutaminase.

Authors:  Maria V Nurminskaya; Alexey M Belkin
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 2.  Molecular determinants of mesenchymal cell activation in fibroproliferative diseases.

Authors:  Loka R Penke; Marc Peters-Golden
Journal:  Cell Mol Life Sci       Date:  2019-09-28       Impact factor: 9.261

3.  Rosiglitazone attenuates activation of human Tenon's fibroblasts induced by transforming growth factor-β1.

Authors:  Fang Fan; Yuehua Li; Xuanchu Duan; Tantai Zhao; Dongning Pan; Huihui Chen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-01-04       Impact factor: 3.117

4.  Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity.

Authors:  Francisco Velez V; Jeffrey A Romano; Robert L McKown; Kari Green; Liwen Zhang; Ronald W Raab; Denise S Ryan; Cindy M L Hutnik; Henry F Frierson; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

5.  Tissue transglutaminase promotes drug resistance and invasion by inducing mesenchymal transition in mammary epithelial cells.

Authors:  Anupam Kumar; Jia Xu; Samuel Brady; Hui Gao; Dihua Yu; James Reuben; Kapil Mehta
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

6.  Review on Hypothetical Implementing TGF-β Family Members in Glaucoma Therapy.

Authors:  Ivan Sosa; Kata Culina; Alan Bosnar
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2012

7.  Hypoxic conditioned medium from human amniotic fluid-derived mesenchymal stem cells accelerates skin wound healing through TGF-β/SMAD2 and PI3K/Akt pathways.

Authors:  Eun Kyoung Jun; Qiankun Zhang; Byung Sun Yoon; Jai-Hee Moon; Gilju Lee; Gyuman Park; Phil Jun Kang; Jung Han Lee; Areee Kim; Seungkwon You
Journal:  Int J Mol Sci       Date:  2014-01-06       Impact factor: 5.923

8.  TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts.

Authors:  Gong Je Seong; Samin Hong; Sun-Ah Jung; Jung-Jin Lee; Eunhae Lim; Sung-Joo Kim; Joon H Lee
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

9.  Effects of mitomycin C on the expression of chymase and mast cells in the conjunctival scar of a monkey trabeculectomy model.

Authors:  Kouhei Okada; Tetsuya Sugiyama; Shinji Takai; Denan Jin; Osamu Ishida; Masanori Fukmoto; Hidehiro Oku; Mizuo Miyazaki; Tsunehiko Ikeda
Journal:  Mol Vis       Date:  2009-10-13       Impact factor: 2.367

10.  Tissue transglutaminase induction in the pressure-overloaded myocardium regulates matrix remodelling.

Authors:  Arti V Shinde; Marcin Dobaczewski; Judith J de Haan; Amit Saxena; Kang-Kon Lee; Ying Xia; Wei Chen; Ya Su; Waqas Hanif; Inderpreet Kaur Madahar; Victor M Paulino; Gerry Melino; Nikolaos G Frangogiannis
Journal:  Cardiovasc Res       Date:  2017-07-01       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.